370 related articles for article (PubMed ID: 26460289)
1. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
[TBL] [Abstract][Full Text] [Related]
2. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
[TBL] [Abstract][Full Text] [Related]
3. Re. "Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease".
Koch C; Chaudru S; Jaquinandi V; Mahé G; Raoult H
Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):605. PubMed ID: 26854210
[No Abstract] [Full Text] [Related]
4. Commentary on 'Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease'.
Rancic ZS
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):394. PubMed ID: 26818023
[No Abstract] [Full Text] [Related]
5. Loss of Kidney Function after Endovascular Treatment of Peripheral Arterial Disease.
Sigterman TA; Bolt LJJ; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GWH; Bouwman LH
Ann Vasc Surg; 2017 Apr; 40():231-238. PubMed ID: 27903484
[TBL] [Abstract][Full Text] [Related]
6. Loss of kidney function in patients with critical limb ischemia treated endovascularly or surgically.
Sigterman TA; Bolt LJ; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GH; Bouwman LH
J Vasc Surg; 2016 Aug; 64(2):362-368. PubMed ID: 27139786
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy.
Kim GS; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
J Vasc Surg; 2015 May; 61(5):1223-30. PubMed ID: 25595408
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.
Lee SR; Zhuo H; Zhang Y; Dahl N; Dardik A; Ochoa Chaar CI
J Vasc Surg; 2020 Aug; 72(2):603-610.e1. PubMed ID: 31843298
[TBL] [Abstract][Full Text] [Related]
9. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
11. Response to Commentary on 'Remote Ischemic Preconditioning to Reduce Contrast Induced Nephropathy: A Randomized Controlled Trial'.
Sigterman T
Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):605-6. PubMed ID: 26733352
[No Abstract] [Full Text] [Related]
12. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
[TBL] [Abstract][Full Text] [Related]
13. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry.
Fujihara M; Kawasaki D; Shintani Y; Fukunaga M; Nakama T; Koshida R; Higashimori A; Yokoi Y;
Catheter Cardiovasc Interv; 2015 Apr; 85(5):870-7. PubMed ID: 25380326
[TBL] [Abstract][Full Text] [Related]
14. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.
Li WH; Li DY; Han F; Xu TD; Zhang YB; Zhu H
Int Urol Nephrol; 2013 Aug; 45(4):1065-70. PubMed ID: 23225080
[TBL] [Abstract][Full Text] [Related]
15. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
[TBL] [Abstract][Full Text] [Related]
16. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature.
Prasad A; Ortiz-Lopez C; Khan A; Levin D; Kaye DM
Catheter Cardiovasc Interv; 2016 Aug; 88(2):264-73. PubMed ID: 26946253
[TBL] [Abstract][Full Text] [Related]
18. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
19. Role of serum cystatin C in the prediction of contrast-induced nephropathy after intra-arterial interventions.
Wang ZY; Wang YL; Wei J; Jin L; Wang ZC
Chin Med J (Engl); 2020 Feb; 133(4):408-414. PubMed ID: 31977562
[TBL] [Abstract][Full Text] [Related]
20. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
